농업과학연구 (Korean Journal of Agricultural Science)

  • 제47권1호
  • /
  • Pages.83-93
  • /
  • 2020
  • /
  • 2466-2402(pISSN)
  • /
  • 2466-2410(eISSN)
충남대학교 농업과학연구소 (Institute of Agricultural Science, CNU)
권호 표지
DOI QR코드

DOI QR Code

Effect of lactoferrin hydrolysates on inflammatory cytokine modulation in HEK-293, RBL-2H3, and HMC-1 cells

  • Son, Ji Yoon (Department of Animal Bio-system Science, College of Agriculture and Life Sciences, Chungnam National University) ;
  • Bae, Hyung Churl (Department of Animal Bio-system Science, College of Agriculture and Life Sciences, Chungnam National University) ;
  • Renchinkhand, Gereltuya (Department of Animal Bio-system Science, College of Agriculture and Life Sciences, Chungnam National University) ;
  • Nam, Myoung Soo (Department of Animal Bio-system Science, College of Agriculture and Life Sciences, Chungnam National University) ;
  • Kim, Woan-sub (Major in Animal Biotechnology, Graduate School of Future Convergence Technology, Hankyong National University)
  • 투고 : 2019.11.12
  • 심사 : 2020.01.15
  • 발행 : 2020.03.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Lactoferrin (LF) is an iron-binding glycoprotein that is present in colostrum, milk, and other body secretions. The objective of this study was to investigate the effects of lactoferrin hydrolysates (LHs) on the production of immunomodulatory factors, including inflammatory related cytokines. The nuclear factor (NF)-κB reporter assay using human embryonic kidney 293 cells (HEK-293) revealed that NF-κB activity was significantly decreased by 1, 50, and 100 ㎍/mL of LH and the fractions above and below the 10 kDa LH. The mRNA expression of interferon (IFN)-γ in rat basophilic leukemia mast cells (RBL-2H3) treated with the fraction above the 10 kDa LH decreased in a dose-dependent manner, but the cells treated with LH and the fraction below the 10 kDa LH showed an increased expression of IFN-γ in a dose-dependent manner. The level of cyclooxygenase (COX)-2 expression decreased dose-dependently in RBL-2H3 cells treated with LH and the fraction above the 10 kDa LH, but the cells treated with the fraction below the 10 kDa LH showed an increased COX-2 expression in a dose-dependent manner. The mRNA expression of interleukin (IL)-4) was dose-dependently decreased by the fraction below the 10 kDa LH in human mast cells (HMC-1). The mRNA expressions of tumor necrosis factor (TNF)-α and IL-6 were significantly dose-dependently decreased by the fractions above and below the 10 kDa LH, but was dose-dependently increased by LH. The production of IL-4 was a little increased by the fraction above the 10 kDa LH compared to the positive control, but was decreased with LH and the fraction below the 10 kDa LH in HMC-1 cells. It was concluded that LF hydrolysates had an immunomodulating effect on anti-, pro-inflammatory and anti-allergic reactions.

키워드

참고문헌

  1. Annane D, Bellisant E, Cavaillon JM. 2005. Septic shock. Lancet 365:63-78. https://doi.org/10.1016/S0140-6736(04)17667-8
  2. Clare DA, Swaisgood HE. 2000. Bioactive milk peptides: A prospectus. Journal of Dairy Science 83:1187-1195. https://doi.org/10.3168/jds.S0022-0302(00)74983-6
  3. Crouch SP, Slater KJ, Fletcher J. 1992. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 80:235-240. https://doi.org/10.1182/blood.v80.1.235.235
  4. Farnaud S, Evans RW. 2003. Lactoferrin-A multifunctional protein with antimicrobial properties. Molecular Immunology 40:395-405. https://doi.org/10.1016/S0161-5890(03)00152-4
  5. FitzGerald RJ, Meisel H. 2003. Milk protein hydrolysates and bioactive peptides. In: Advances in Dairy Chemistry. 3rd edited by Fox PF, and Mc Sweeney PLH. pp. 657-698. Kluwer Academic/Plenum Publishers, NY, USA.
  6. Galli SJ, Gordon JR, Wershil BK. 1992. Cytokine production by mast cells and basophils. Current Opinion in Immunology 3:865-872. https://doi.org/10.1016/S0952-7915(05)80005-6
  7. Haversen L, Ohlsson BG, Hahn-Zoric M, Hanson LA, Mattsby-Baltzer I. 2002. Lactoferrin down-regulates the LPSinduced cytokine production in monocytic cells via NF-kappa B. Cellular Immunology 220:83-95. https://doi.org/10.1016/S0008-8749(03)00006-6
  8. Kawai K, Shimazaki K, Higuchi H, Nagahata H. 2007. Antibacterial activity of bovine lactoferrin hydrolysate against mastitis pathogens and its effect on superoxide production of bovine neutrophils. Zoonoses and Public Health 54:160-164. https://doi.org/10.1111/j.1863-2378.2007.01031.x
  9. Kitts DD, Weiler K. 2003. Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Current Pharmaceutical Design 9:1309-1323. https://doi.org/10.2174/1381612033454883
  10. Korhonen H, Pihlanto A. 2007. Bioactive peptides from food proteins. Handbook of food products manufacturing. Edited by Hui YH. pp. 5-37. John Wiley&Sons, Inc., California, USA.
  11. Kruzel ML, Harari Y, Mailman D, Actor JK, Zimecki M. 2002. Differential effects of prophylactic, concurrent and the rapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice. Clinical & Experimental Immunology 130:25-31. https://doi.org/10.1046/j.1365-2249.2002.01956.x
  12. Legrand D, Elass E, Carpentier M, Mazurier J. 2005. Lactoferrin: A modulator of immune and inflammatory responses. Cellular and Molecular Life Science 62:2549-2559. https://doi.org/10.1007/s00018-005-5370-2
  13. Li G, Le G, Shi Y, Shrestha S. 2004. Angiotensin 1-converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects. Nutrition Research 24:469-486. https://doi.org/10.1016/S0271-5317(04)00058-2
  14. Metcalfe DD, Baram D, Mekori YA. 1997. Mast cells. Physiological Reviews 77:1033-1079. https://doi.org/10.1152/physrev.1997.77.4.1033
  15. Moon TC, Murakami M, Ashraf MD, Kudo I, Chang HW. 1998. Regulation of cyclooxygenase-2 and endogenous cytokine expression by bacterial lipopolysaccharide that acts in synergy with c-kit ligand and $Fc{\varepsilon}RI$ crosslinking in cultured mast cells. Cellular Immunology 185:146-152. https://doi.org/10.1006/cimm.1998.1284
  16. Nadler MJS, Matthews SA, Turner HA, Kinet JP. 2000. Signal transduction by the high-affinity immunoglobulin E receptor Fc epsilon RI: Coupling form to function. Advances in Immunology 76:325-355.
  17. Park YW, Nam MS. 2015. Bioactive peptides in milk and dairy products: Review. Korean Journal for Food Science of Animal Resources 35:831-840. https://doi.org/10.5851/kosfa.2015.35.6.831
  18. Sindayikengera S, Xia W. 2006. Nutrition evaluation of casein and whey proteins and their hydrolysates from Protamex. Journal of Zhejiang University Science B 7:90-98. https://doi.org/10.1631/jzus.2006.B0090
  19. Son JY, Park YW, Renchinkhand G, Paik SH, Nam MS. 2018. Characterization of lactoferrin hydrolysates on inflammatory cytokine expression in RAW264.7 macrophage. Korean Journal of Agricultural Science 45:439-448. [in Korean]
  20. Stancius N, Hintoiu A, Stanciu S, Rapeanu G. 2010. Thermal treatment can modify the susceptibility of whey protein concentrate to enzymatic hydrolysis. Innovative Romanian Food Biotechnology 7:30-36.
  21. Togawa J, Nagase H, Tanaka K, Inamori M, Nakajima A, Ueno N, Saito T, Sekihara H. 2002. Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. Journal of Gastroenterology and Hepatology 17:1291-1298. https://doi.org/10.1046/j.1440-1746.2002.02868.x
  22. Wakabayashi H, Takakura N, Teraguchi S, Tamura Y. 2003. Lactoferrin feeding augments peritoneal macrophage activities in mice intraperitoneally injected with inactivated candida albicans. Microbiology Immunology 47:37-43. https://doi.org/10.1111/j.1348-0421.2003.tb02783.x
  23. Yamaguchi M, Matsuura M, Kobayashi K, Sasaki H, Yajima T, Kuwata T. 2001. Lactoferrin protects against development of hepatitis caused by sensitization of kupffer cells by lipopolysaccharide. Clinical and Diagnostic Laboratory Immunology 8:1234-1239. https://doi.org/10.1128/CDLI.8.6.1234-1239.2001

피인용 문헌

  1. 수면 장애 및 아토피피부염에 효과적인 7 가지 한약 처방의 항염증 활성 연구 vol.35, pp.2, 2020, https://doi.org/10.15188/kjopp.2021.02.35.2.56